Ellington Management Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,200
Closed -$450K 789
2019
Q4
$450K Buy
+2,200
New +$450K 0.1% 179